Semantic Feature Analysis Treatment for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two versions of a treatment called Semantic Feature Analysis, which helps people with aphasia improve their ability to name things. Aphasia, often caused by a stroke, is a language disorder that makes speaking or understanding words difficult. Researchers aim to determine which version of the treatment works better and how it affects the brain. Ideal candidates for this trial include individuals who experienced a left-side stroke causing aphasia at least six months ago and can manage daily tasks independently or with assistance. Participants should not have other neurological issues and must not be in any other speech therapy during the study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future aphasia treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does require that you do not participate in any other speech-language treatment during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Semantic Feature Analysis (SFA) is an effective method for helping people with aphasia, a language disorder. This therapy targets naming difficulties, which are common in aphasia.
Studies have found that SFA is generally well-received. For example, one study found that participants who underwent SFA therapy improved their ability to name items by about 20% for practiced items. This suggests that SFA can be both safe and effective for enhancing language skills in people with aphasia.
These studies have reported no major side effects, highlighting the safety of SFA for people with aphasia. As a form of speech therapy rather than a new drug, this treatment generally carries lower risks compared to medication-based treatments.12345Why are researchers excited about this trial?
Researchers are excited about the Semantic Feature Analysis (SFA) Treatment for aphasia because it offers a unique approach to improving language abilities. Unlike traditional speech therapy that may focus broadly on communication skills, SFA specifically enhances the patient's ability to retrieve and produce words by exploring their semantic features—like what a word looks like or how it's used. This trial compares a modified version of SFA with the standard approach, potentially leading to more personalized and effective interventions for people with aphasia. By targeting the cognitive processes involved in word retrieval, SFA could offer faster and more robust improvements in language function.
What evidence suggests that this trial's treatments could be effective for aphasia?
Studies have shown that Semantic Feature Analysis (SFA) helps people with aphasia improve their naming abilities. It tends to work better for those with fluent aphasia, but it can also benefit those with non-fluent aphasia. Research indicates that most participants find it easier to name objects they previously struggled with after using SFA. While results can vary, the treatment generally leads to positive outcomes. This trial will compare two versions of SFA: a modified version for one group of participants and a standard version for another group, to determine which is more effective.678910
Who Is on the Research Team?
William D Hula, Ph.D.
Principal Investigator
VA Pittsburgh Healthcare System
Patrick J Doyle, Ph.D.
Principal Investigator
VA Pittsburgh Healthcare System
Are You a Good Fit for This Trial?
This trial is for individuals who have aphasia due to a stroke in the left side of their brain, at least 6 months ago. They must be able to manage daily activities on their own or with help from a caregiver, and not have uncontrolled health issues like seizures. Participants should speak English as their first language and not be involved in other speech treatments during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 60 hours of Semantic Feature Analysis treatment over a five-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment, including language, eye-tracking, and fMRI testing
What Are the Treatments Tested in This Trial?
Interventions
- Semantic Feature Analysis Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Pittsburgh Healthcare System
Lead Sponsor
Penn State University
Collaborator